Condition: Arthritis (Hip) · Hip Dysplasia, Congenital · Sponsor: Medacta International SA
The goal of this observational study is to collect clinical and radiological data to monitor the safety and performance of the ROMAX hip resurfacing system. The main parameter that will be measured is the rate of revisions at 10 years.
This description comes directly from the study's public registry record.
Marco Viganò, PhD · +41 0916966060 · m.vigano@medacta.ch
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire de Lille | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06775704